ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $939 | +51.7% | 34,942 | +101.4% | 0.01% | +66.7% |
Q2 2023 | $619 | +56.3% | 17,347 | +11.2% | 0.01% | +50.0% |
Q1 2023 | $396 | -37.4% | 15,602 | 0.0% | 0.00% | -42.9% |
Q4 2022 | $633 | -99.9% | 15,602 | 0.0% | 0.01% | +16.7% |
Q3 2022 | $515,000 | -17.6% | 15,602 | +14.7% | 0.01% | 0.0% |
Q1 2022 | $625,000 | -35.4% | 13,600 | -6.8% | 0.01% | -33.3% |
Q4 2021 | $968,000 | +6.3% | 14,600 | 0.0% | 0.01% | +12.5% |
Q3 2021 | $911,000 | -24.6% | 14,600 | 0.0% | 0.01% | -27.3% |
Q2 2021 | $1,209,000 | +24.9% | 14,600 | 0.0% | 0.01% | +10.0% |
Q1 2021 | $968,000 | -21.6% | 14,600 | -9.3% | 0.01% | -16.7% |
Q4 2020 | $1,235,000 | +78.2% | 16,100 | 0.0% | 0.01% | +50.0% |
Q3 2020 | $693,000 | -9.1% | 16,100 | -8.8% | 0.01% | -11.1% |
Q2 2020 | $762,000 | +12.9% | 17,655 | -24.8% | 0.01% | 0.0% |
Q1 2020 | $675,000 | -60.6% | 23,476 | -13.1% | 0.01% | -52.6% |
Q4 2019 | $1,712,000 | +120.9% | 27,000 | -1.8% | 0.02% | +111.1% |
Q3 2019 | $775,000 | +6.3% | 27,500 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $729,000 | – | 27,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |